can you take glp 1 if you have ulcerative colitis Weight Loss Injections with Colitis? GLP-1 Receptor Agonists in Obese

Side effects are usually mild to moderate, and in the clinical trials more than 90% of those treated with semaglutide / Wegovy and tirzepatide / Zepbound were able to stay on the medications

Animal studies indicate a potential risk of thyroid C-cell tumors, raising concerns about medullary thyroid cancer in humans, though clinical trials havent confirmed this link

Build up fiber slowly

Novo Nordisk A/S Key Target Audience Market Players Investors End-users Government Authorities Consulting and Research Firm Venture capitalists Value-Added Resellers (VARs) Recent Development In January 2023, Semaglutide (Wegovy- Novo Nordisk) has been licensed by the US Food and Drug Administration for the treatment of obesity in pediatric patients aged 12 and above